Jb. Tyrrell et Cb. Wilson, CUSHINGS-DISEASE - THERAPY OF PITUITARY-ADENOMAS, Endocrinology and metabolism clinics of North America, 23(4), 1994, pp. 925-938
The treatment of Cushing's disease has evolved over the past 20 years
from the era of bilateral adrenalectomy to the current era of pituitar
y microsurgery.(5, 32, 53, 68) Therapy directed to the pituitary is cu
rrently the first approach in Gushing's disease and transsphenoidal ex
ploration of the sellar contents is the procedure of choice.(40, 42) P
ituitary microsurgery is successful in the majority of patients with m
icroadenomas but considerably less so in those with larger or invasive
tumors. In these latter patients, radiotherapy is usually the modalit
y of second choice and may be combined with medical therapy to inhibit
adrenal cortisol production or less commonly medical therapy to inhib
it adrenocorticotropic hormone (ACTH) secretion. Primary treatment wit
h the various techniques of delivering radiation to the sella turcica
is rarely used at present and the pharmacologic inhibition of ACTH sec
retion has been largely unsuccessful, as discussed later.